Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Kyung Ju Ryu"'
Autor:
Sang Eun Yoon, Sujin Park, Junhun Cho, Kyung Ju Ryu, Booma Yandava, Sewon Lee, Seok Jin Kim, Won Seog Kim
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionSoluble MHC class I-related chain A (sMICA) and B (sMICB) play a critical role tumor evolution and poor prognosis through an immune evasion mechanism. Thus, this study determines the interaction between sMICA/sMICB and the tumor immune en
Externí odkaz:
https://doaj.org/article/745c8b0762bd4e0ab1222c844cf50db1
Autor:
Inju Cho, Hansang Lee, Sang Eun Yoon, Kyung Ju Ryu, Young Hyeh Ko, Won Seog Kim, Seok Jin Kim
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background The interaction of programmed death-1 protein (PD-1) and programmed death-1 ligand (PD-L1) produces immunosuppressive activity, protecting tumor cells from anti-tumor immunity and possibly releasing soluble PD-L1 (sPD-L1) from PD-
Externí odkaz:
https://doaj.org/article/e025391a47fb4797a9216b0a6969cef2
Autor:
Seok Jin Kim, Mineui Hong, In-Gu Do, Seung Ho Lee, Kyung Ju Ryu, Hae Yong Yoo, Jung Yong Hong, Young Hyeh Ko, Won Seog Kim
Publikováno v:
Haematologica, Vol 100, Iss 3 (2015)
Externí odkaz:
https://doaj.org/article/3064cd49de7549c2910d44a1879abdb8
Autor:
Seok Jin, Kim, Yeon Jeong, Kim, Sang Eun, Yoon, Kyung Ju, Ryu, Bon, Park, Donghyun, Park, Duck, Cho, Hyun-Young, Kim, Junhun, Cho, Young Hyeh, Ko, Woong-Yang, Park, Won Seog, Kim
Publikováno v:
Cancer Research and Treatment. 55:291-303
Purpose Plasma circulating tumor DNA (ctDNA) could reflect the genetic alterations present in tumor tissues. However, there is little information about the clinical relevance of cell-free DNA genotyping in peripheral T-cell lymphoma (PTCL).Materials
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fcd2a592101a5251e0aaf3593261c10
https://doi.org/10.4143/crt.2022.017
https://doi.org/10.4143/crt.2022.017
Autor:
Yeong Hak, Bang, Joon Ho, Shim, Kyung Ju, Ryu, Yeon Jeong, Kim, Myung Eun, Choi, Sang Eun, Yoon, Junhun, Cho, Bon, Park, Woong-Yang, Park, Won Seog, Kim, Seok Jin, Kim
Publikováno v:
Journal of Cancer. 13:1388-1397
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2abf113f810c1b828ab278a2e5582151
https://doi.org/10.7150/jca.69639
https://doi.org/10.7150/jca.69639
Autor:
Kyung Ju Ryu, Sung Won Lim, Seok Jin Kim, Sang Eun Yoon, Chaehwa Park, Myung Eun Choi, Ji Young Lee, Kihyun Kim, Daeun Ryu
Publikováno v:
Journal of Cancer
Background: Exosomes have emerged as important mediators of tumor progression, and a prognostic role for serum exosomal miRNAs has been suggested in multiple myeloma (MM). Given the association of hypoxia with tumor aggressiveness, including cancer s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::620e46437753264c1878cec98bcaf0b6
https://doi.org/10.7150/jca.55553
https://doi.org/10.7150/jca.55553
Publikováno v:
Cancers; Volume 14; Issue 22; Pages: 5618
Soluble and exosomal programed death-ligand 1 (PD-L1) can be upregulated in extranodal natural killer/T-cell lymphoma (ENKTL). However, its clinical role in predicting outcomes after pembrolizumab treatment has yet to be studied in ENKTL patients. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef7ebcf453be4de78b70e36d35058aad
https://doi.org/10.3390/cancers14225618
https://doi.org/10.3390/cancers14225618
Publikováno v:
Cytokine. 113:371-379
To better predict the outcomes of patients with peripheral T-cell lymphoma (PTCL), we measured the levels of various cytokines in serum samples from patients with PTCL and analyzed their clinical outcomes. We measured 34 cytokines in samples from 121
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67611e5ea198bc8a04a75e0e715b3783
https://doi.org/10.1016/j.cyto.2018.10.009
https://doi.org/10.1016/j.cyto.2018.10.009
Autor:
Sang Eun Yoon, Ji Young Lee, Youngil Koh, Duck Cho, Mette Bjerre, Soon Thye Lim, Jing Quan Lim, Seok Jin Kim, Kyung Ju Ryu, Francesco d'Amore, Yurike Laurensia, Won Seog Kim, Junhun Cho, Young Hyeh Ko, Choon Kiat Ong, Marie Beck Enemark
Publikováno v:
Kim, S J, Lim, J Q, Laurensia, Y, Cho, J, Yoon, S E, Lee, J Y, Ryu, K J, Ko, Y H, Koh, Y, Cho, D, Lim, S T, Beck Enemark, M, D'amore, F, Bjerre, M, Ong, C K & Kim, W S 2020, ' Avelumab for the treatment of relapsed or refractory extranodal NK/T-cell lymphoma: an open-label phase 2 study ', Blood, vol. 136, no. 24, pp. 2754-2763 . https://doi.org/10.1182/blood.2020007247
This study aimed to assess the efficacy and safety of treatment with avelumab, an anti–programmed death ligand 1 (PD-L1) antibody, in patients with relapsed or refractory extranodal natural killer/T-cell lymphoma (ENKTL). In this phase 2 trial, 21
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ffb8cd18a30f3084094acf77b99f4b6
https://pure.au.dk/portal/da/publications/avelumab-for-the-treatment-of-relapsed-or-refractory-extranodal-nktcell-lymphoma-an-openlabel-phase-2-study(088b25b6-d9c4-4edd-bca6-ae0843286f11).html
https://pure.au.dk/portal/da/publications/avelumab-for-the-treatment-of-relapsed-or-refractory-extranodal-nktcell-lymphoma-an-openlabel-phase-2-study(088b25b6-d9c4-4edd-bca6-ae0843286f11).html
Autor:
Myung Eun Choi, Kyung Ju Ryu, Chaehwa Park, Seok Jin Kim, Won Seog Kim, Young Hyeh Ko, Junhun Cho, Sang Eun Yoon, Ji Young Lee, Joon Ho Shim
Publikováno v:
Cancers
Cancers, Vol 12, Iss 3548, p 3548 (2020)
Volume 12
Issue 12
Cancers, Vol 12, Iss 3548, p 3548 (2020)
Volume 12
Issue 12
Exosomes containing microRNAs (miRNAs) might have utility as biomarkers to predict the risk of treatment failure in extranodal NK/T-cell lymphoma (ENKTL) because exosomal cargo miRNAs could reflect tumor aggressiveness. We analyzed the exosomal miRNA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72f222991a89ea6c6904568e6aba4a11
https://pubmed.ncbi.nlm.nih.gov/33261029
https://pubmed.ncbi.nlm.nih.gov/33261029